Coherus Oncology, Inc. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $202.00K, a 7.45% increase year-over-year.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-06-30 was $188.00K, a 72.55% decline year-over-year.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2024-06-30 was $685.00K, a 48.77% decline year-over-year.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for the quarter ending 2023-06-30 was $1.34M, a 19.21% decline year-over-year.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $353.00K, a 61.88% decline from fiscal 2024.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $926.00K.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $2.32M, a 22.72% decline from fiscal 2021.
- Coherus Oncology, Inc. stock issued during period, value, employee stock purchase plan for fiscal 2021 was $3.00M, a 21.02% decline from fiscal 2020.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $202.00K 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $353.00K 10-K · filed 2026-03-09 | |
| 2025-06-30 | $188.00K 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $926.00K 10-K · filed 2026-03-09 | |
| 2024-06-30 | $685.00K 10-Q · filed 2025-11-06 | |
| 2023-12-31 | $1.81M 8-K · filed 2025-11-13 | |
| 2023-06-30 | $1.34M 10-Q · filed 2024-11-06 | |
| 2022-12-31 | $2.32M 10-K · filed 2025-03-17 | |
| 2022-06-30 | $1.66M 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $3.00M 10-K · filed 2024-03-15 | |
| 2021-06-30 | $1.99M 10-Q · filed 2022-11-08 | |
| 2020-12-31 | $3.80M 10-K · filed 2023-03-06 | |
| 2020-06-30 | $2.56M 10-Q · filed 2021-11-08 | |
| 2020-03-31 | $2.38M 10-Q · filed 2021-11-08 | |
| 2019-12-31 | $3.52M 10-K · filed 2022-02-23 | |
| 2019-06-30 | $1.88M 10-Q · filed 2019-11-08 | |
| 2018-12-31 | $1.59M 10-K · filed 2021-02-25 | |
| 2018-06-30 | $764.00K 10-Q · filed 2019-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |